drugset / Trial / NCT00323947

Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy

NCT00323947

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will evaluate the safety and effectiveness of extended release methylphenidate (XR-MPH) in treating attention deficit hyperactivity disorder (ADHD) in children with both ADHD and epilepsy.

Timeline

Start
2003-05
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule 18 mg
Comparator Methylphenidate Small molecule 36 mg
Comparator Methylphenidate Small molecule 54 mg